Over 200 Total Lots Up For Auction at Two Locations - UT 10/25, CA 10/28

FDA clears Siemens' 'low cost of ownership' 3T MRI

by Brendon Nafziger, DOTmed News Associate Editor | July 24, 2012
Siemens' Magetom Spectra (Credit: Siemens)
A new 3-Tesla MRI scanner marketed as less expensive and more accessible to providers than most 3T units received Food and Drug Administration 510(k) clearance, Siemens Healthcare announced Tuesday.

The scanner, called the Magnetom Spectra, is pitched as a high-end device with a lower total cost of ownership, according to Siemens' promotional materials. The device uses less energy than other 3T MRIs and the magnet-cooling helium doesn't need to be refilled as often, as it travels in a closed loop to prevent gas from escaping, Siemens said in its press release.

"The Magnetom Spectra developed by Siemens is an MRI scanner that will enable many radiologists to utilize 3-Tesla imaging for the first time," Dr. Axel McKenna-Küttner, a radiologist in Germany, whose clinic was evaluating the Magnetom Spectra, said in a statement in March, when the device was announced.
stats
DOTmed text ad

Our 10th Anniversary Sale is almost over - do not miss your chance to save!

Final days to save an extra 10% on Imaging, Ultrasound, and Biomed parts web prices.* Unlimited use now through September 30 with code AANIV10 (*certain restrictions apply)

stats
While the cost of the device was not disclosed in the release, the average price tag for a 3T MRI unit is about $2.4 million, according to a recent ECRI Institute report.

According to a product brochure, the Magnetom Spectra features 24 radiofrequency channels for up to 120 coil elements and a whole-body scan range of up to 205 centimeters. The coils are part of Siemens' fourth generation "Tim," or total imaging matrix, technology.
(1)

richard stoncius

Spectra picture provided by Siemens.

July 28, 2012 10:39

The picture of the Spectra looks like a picture of the Skyra.

Log inor Register

to rate and post a comment

You Must Be Logged In To Post A Comment